TY - BOOK AU - Warrell,D.A. AU - Gutiérrez,J-M ED - World Health Organization. TI - Rabies and envenomings: a neglected public health issue : report of a consultative meeting, World Health Organization, Geneva, 10 January 2007 SN - 9789241563482 AV - RD96.2 W37 2007 PY - 2007/// CY - Geneva PB - World Health Organization KW - Rabia KW - Pacientes KW - Cuidades médicos KW - lemb KW - Epidemiología KW - Quimioterapia KW - Mordeduras y picaduras KW - Cuidados médicos KW - Sueros inmunes KW - Uso terapeútico KW - Animales venenosos KW - Venenos animales KW - Efectos fisiológicos KW - Rabies KW - Patients KW - Medical care KW - Epidemiology KW - Chemotherapy KW - Bites and stings KW - Immune serums KW - Therapeutic use KW - Poisonous animals KW - Venom KW - Physiological effect N1 - "This Report was developed by compiling the information provided at the WHO Consultative Meeting on Rabies and Envenomings: a Neglected Public Health Issue that took place at WHO, Geneva on 10 January 2007"--T.p. verso; Incluye referencias bibliográficas (p. 29-30); Introduction -- Rabies and envenomings : neglected diseases -- Epidemiology : the burden of disease -- Production and control of therapeutic antisera -- Distribution and appropriate use of therapeutic antisera : failure to supply those at greatest need -- Scales of production : the need to strengthen capacity -- Prequalification of antisera : the way to improve access to quality and safe products -- Towards a global solution : a WHO intiative to improve availability of safe antisera N2 - The aim of this consultative meeting was to discuss strategies for improving the quality and quantity of therapeutic antisera, essential drugs for the effective treatment of suspected rabid dog bites and envenoming by snake bites and scorpion stings. Inadequacies in the efficacy, safety and production of these antisera have created a major global public health crisis, especially in Africa and Asia. Each year, millions of people are bitten by dogs or snakes or stung by scorpions and the failure to provide antisera costs at least 150,000 lives and at least as many cases of permanent physical handicap. The solution to this crisis demands an international effort to promote transfer of technology to affected countries, to improve standards through the WHO's prequalification scheme and to facilitate distribution of antisera and training of medical personnel in their optimal use.--Publisher's description UR - http://www.who.int/bloodproducts/animal_sera/Rabies.pdf ER -